N⁶-Methyladenosine-regulated LINC00675 suppress the proliferation, migration and invasion of breast cancer cells via inhibiting miR-513b-5p

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021 Apr 5;149(4):778–789.
   Web of Science ®Google Scholar
• Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17(S3):43–46.
   PubMedGoogle Scholar
• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017 Aug 1;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018 Jan 25;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Kozlowska J, Kolenda T, Poter P, et al. Long intergenic non-coding RNAs in HNSCC: from “Junk DNA” to important prognostic factor. Cancers (Basel). 2021 Jun 12;13(12):2949.
   Web of Science ®Google Scholar
• Liang Y, Song X, Li Y, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer. 2020 May 8;19(1):85.
   PubMed Web of Science ®Google Scholar
• Ma F, Liu X, Zhou S, et al. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop. Cancer Lett. 2019;450:63–75.
   PubMed Web of Science ®Google Scholar
• Li DD, Fu ZQ, Lin Q, et al. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. World J Gastroenterol. 2015 Aug 21;21(31):9348–9357.
   PubMed Web of Science ®Google Scholar
• Zeng S, Xie X, Xiao YF, et al. Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression. Cancer Lett. 2018;412:179–187.
   PubMed Web of Science ®Google Scholar
• Ma S, Deng X, Yang Y, et al. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/beta-catenin signaling in cervical cancer. Biomed Pharmacothe. 2018 Dec;108:1686–1693.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Wang Q. LINC00675 is a prognostic factor and regulates cell proliferation, migration and invasion in glioma. Biosci Rep. 2018;38(5). DOI:10.1042/BSR20181039.
   Google Scholar
• Zhong YB, Shan AJ, Lv W, et al. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/beta-catenin signaling in esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8288–8297.
   PubMed Web of Science ®Google Scholar
• Yao M, Shi X, Li Y, et al. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Cell Death Dis. 2020 Aug 15;11(8):638.
   PubMed Web of Science ®Google Scholar
• Yang D, Qiao J, Wang G, et al. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Res. 2018 May 4;46(8):3906–3920.
   PubMed Web of Science ®Google Scholar
• Yang G, Sun Z, Zhang N. Reshaping the role of m6A modification in cancer transcriptome: a review. Cancer Cell Int. 2020;20:353.
   PubMed Web of Science ®Google Scholar
• Lang C, Yin C, Lin K, et al. m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med. 2021 Jun;11(6):e426.
   PubMed Web of Science ®Google Scholar
• Wu J, Pang R, Li M, et al. m6A-induced LncRNA MEG3 suppresses the proliferation, migration and invasion of hepatocellular carcinoma cell through miR-544b/BTG2 signaling. Onco Targets Ther. 2021;14:3745–3755.
   PubMed Web of Science ®Google Scholar
• Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014 May 12;25(5):666–681.
   PubMed Web of Science ®Google Scholar
• Li T, Xie J, Shen C, et al. Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res. 2015 Aug 1;75(15):3181–3191.
   PubMed Web of Science ®Google Scholar
• Wang L, Cho KB, Li Y, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22). DOI:10.3390/ijms20225758.
   Web of Science ®Google Scholar
• Qin L, Zhan Z, Wei C, et al. HsacircRNAG004213 promotes cisplatin sensitivity by regulating miR513b5p/PRPF39 in liver cancer. Mol Med Rep. 2021 Jun;23(6). DOI:10.3892/mmr.2021.12060.
   Web of Science ®Google Scholar
• Zhang Z, Wu X, Han Q, et al. Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis. Anticancer Drugs. 2021 Feb 15. DOI:10.1097/CAD.0000000000001034.
   Web of Science ®Google Scholar
• Wang X, Zhang X, Wang G, et al. Hsa-miR-513b-5p suppresses cell proliferation and promotes P53 expression by targeting IRF2 in testicular embryonal carcinoma cells. Gene. 2017 Aug 30;626:344–353.
   PubMed Web of Science ®Google Scholar
• Lin W, Ye H, You K, et al. Up-regulation of circ_LARP4 suppresses cell proliferation and migration in ovarian cancer by regulating miR-513b-5p/LARP4 axis. Cancer Cell Int. 2020;20:5.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang L, Ding X, et al. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR513b5p and regulating the PTEN/AKT/mTOR signaling pathway. Mol Med Rep. 2021 Jan;23(1). DOI:10.3892/mmr.2020.11662.
   Web of Science ®Google Scholar
• Pan Y, Fang Y, Xie M, et al. LINC00675 suppresses cell proliferation and migration via downregulating the H3K4me2 level at the SPRY4 promoter in gastric cancer. Mol Ther Nucleic Acids. 2020;22:766–778.
   PubMedGoogle Scholar
• Shan Z, An N, Qin J, et al. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/beta-catenin signaling. Biomed Pharmacothe. 2018 May;101:769–776.
   PubMed Web of Science ®Google Scholar
• Tian Y, Zeng Z, Li X, et al. Transcriptome-wide stability analysis uncovers LARP4-mediated NFkappaB1 mRNA stabilization during T cell activation. Nucleic Acids Res. 2020 Sep 4;48(15):8724–8739.
   PubMed Web of Science ®Google Scholar
• Egiz M, Usui T, Ishibashi M, et al. La-related protein 4 as a suppressor for motility of ovarian cancer cells. Tohoku J Exp Med. 2019 Jan;247(1):59–67.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xu J, Du Q, et al. IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating beta-catenin. Transl Oncol. 2021 Jun;14(6):101059.
   PubMed Web of Science ®Google Scholar
• Kriegsman BA, Vangala P, Chen BJ, et al. Frequent loss of IRF2 in cancers leads to immune evasion through decreased MHC class I antigen presentation and increased PD-L1 expression. J Immunol. 2019 Oct 1;203(7):1999–2010.
   PubMed Web of Science ®Google Scholar
• Carbognin L, Miglietta F, Paris I, et al. Prognostic and predictive implications of PTEN in breast cancer: unfulfilled promises but intriguing perspectives. Cancers (Basel). 2019 Sep 19;11(9):1401.
   Web of Science ®Google Scholar
• Cai X, Wang X, Cao C, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;415:11–19.
   PubMed Web of Science ®Google Scholar
• Jin H, Ying X, Que B, et al. N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. 2019 Sep;47:195–207.
   PubMed Web of Science ®Google Scholar
• Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019 Mar 28;18(1):46.
   PubMed Web of Science ®Google Scholar